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Objectives In August 2008 the British reality TV star Jade Goody made public her diagnosis of
cervical cancer. In February 2009 it was announced that she was terminally ill and she died a few
weeks later. A surge in cervical screening attendances associated with these events was widely
reported. This paper aims to quantify the size of that effect across England, its duration, and
whether it affected some groups of women more than others.
Setting The Cervical Screening Programme in England.
Methods Routinely collected statistics for the months around Jade Goody’s diagnosis and death
were compared with those for other periods.
Results About half a million extra cervical screening attendances occurred in England between mid-
2008 and mid-2009, the period during which Jade Goody was diagnosed and died; among these
were 370 attendances where the test result was suspected neoplasia. At its peak in March 2009,
attendance was 70% higher than expected. Increases were seen in both initial and follow-up
screening attendances and in colposcopy attendances, and at all ages, though the magnitude was
greater for women aged under 50. A substantially greater proportion of the extra attendances of
women aged 25–49 on routine recall occurred in women whose attendance was overdue (28%
occurred at 60 months or more) and relatively little represented over-screening (8% had been
screened within the last 30 months).
Conclusions The pattern of increased attendance mirrored the pattern of media coverage of Jade
Goody’sdiagnosisanddeath.It islikelythattheincreasedscreeningresultedinanumberof livessaved.
INTRODUCTION
S
creening behaviour may be affected by many factors.
Health services and screening programmes them-
selves seek to maintain coverage at a high level
through regular positive publicity, while recognizing the
need at an individual level to provide information on both
beneﬁts and risks and to support informed choice. The
media can also stimulate behaviour changes by including
screening (or diseases screened for) in the storylines of
popular shows;
1 and publicity given to ‘celebrities’ who are
diagnosed with such diseases can also lead to changes in be-
haviour of persons for whom they may be in some way role
models.
2
Jade Goody died of cervical cancer in March 2009, having
been ﬁrst diagnosed in the previous August; she was aged
27. Shortly before her death, when it was announced that
she was terminally ill, reports began to appear of a substan-
tial increase in the number of women undergoing cervical
screening.
3 The annual statistics for 2008–09 showed an
increase in cervical screening coverage after many years of
gradual decline; furthermore, coverage remained at this
higher level in 2009–10.
4 We used data from the cervical
screening call-recall database (the ‘Exeter’ system) to assess
the magnitude and durability of the ‘Jade Goody’ effect.
METHODS
The Exeter database holds information about all invitations
and cytology tests on women invited for cervical screening.
In England, women aged between 25 and 49 are invited
every three years and those aged between 50 and 64 every
ﬁve years. This is a recent change from screening women
aged 20–64 ‘at least ﬁve-yearly’, which was variously inter-
preted locally as every three, four or ﬁve years. Annual and
monthly data about attendances were obtained from 2004
onwards. The information extracted included women’s
age, region of residence, category of invitation, screening
status (i.e. whether they had been previously invited or
screened and, if so, how recently) and test result.
The data were extracted using the deﬁnitions for creating
the tables in the annual statistical bulletin, with one excep-
tion. Those women who have screening tests without
being prompted by the programme are counted in the bulle-
tins as having been tested outside the screening programme.
For this analysis, all women are counted as having been
tested within the programme, other than those invited pri-
vately or those with no prior recall type (i.e. those not yet
called).
The extracts on which this analysis is based were taken in
October/November 2010. As the databases are continually
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extracted differs slightly from corresponding numbers in
the published bulletins; in all years, the numbers in these
extracts are the higher – in 2008–09 by about 40,000
attendances, or 1% of the total.
The number of attendances routinely varies from month
to month. In order to estimate the excess of tests taken in
the months affected by the publicity surrounding Jade
Goody’s diagnosis and death, Poisson regression models
were ﬁtted to the counts for all other months assuming
that the numbers of attendances are inﬂuenced both by a
seasonal effect and a smoothly varying time effect.
Different models were ﬁtted to different age-groups and
different categories of test (e.g. type of invitation, time
since last test, etc.). The seasonal effect was modelled by
allowing a separate multiplicative factor for each calendar
month and the time effect was modelled in Stata as a
natural cubic spline.
5 Within the model, terms for other
factors (e.g. age and invitation type) were also included.
The differences between the observed numbers in the
months of particular interest and those predicted by the
model (applied to all other months) were taken to be
the excess in those months. These residuals could either
be positive or negative, but on average they are zero for the
months on which the models are ﬁtted. It is their values in
the months surrounding Jade Goody’s diagnosis and death
that are taken as the estimated extra number of attendances.
Analysis was performed to examine whether there were
variations in the response to the publicity by age, reason
for/category of test, time since last test (where expected
date of testing varies according to reason for test) and
region. In order to estimate the numbers of women tested
who might never have returned to the screening programme
without the publicity about a celebrity’s illness and death, it
was assumed that all tests for such women were included
among the excess tests; that all the tests occurred at least
six months beyond the programme standard for early
repeat tests, and beyond 60 months for routine recall; and
that the distributions by time since last test for excess tests
of all other women were similar to the respective usual
underlying distributions by time since last test.
Published data from colposcopy were also examined fol-
lowing anecdotal reports of women who had previously
failed to attend for follow up of an abnormal cytology
result now reinstating their appointments and attending.
These data are not held on the Exeter database. Finally,
we analysed press coverage of the events in order to
attempt to correlate screening activity with the publicity.
RESULTS
In the period 2002–03 to 2005–06 there were 4.0 million
screening attendances in each year. The number then fell
in 2006–07 and 2007–08 to 3.6 million, rose to 4.0
million again in 2008–09 and fell back again to 3.6
million in 2009–10. This very broad analysis suggests that
about 0.4 million extra attendances occurred in 2008–09,
the year of Jade Goody’s diagnosis and death.
The raw monthly data show a more speciﬁc timing for
these extra attendances when comparing the year of interest
with the same months of the previous year (Figure 1). The
attendance ﬁgure in September 2008 was about 30%
above that in September 2007, and October 2008 higher,
by about 10%, than October 2007; Jade Goody’s diagnosis
was made public on 19th August 2008. A far more marked
spike in attendances occurred in early 2009. The number
of attendances in February 2009 was about 15% higher
than in February 2008. Attendances peaked in March at a
level just under double that of March 2008 (and 67%
greater than expected taking into account other trends);
then they fell back to about 15% higher than the corre-
sponding month of the previous year, to about 5% higher
in June which could be routine variation and therefore the
data from this month have not been included as extra
attendances in the analyses. From July onwards, attendance
ﬁgures were lower in 2009 than in corresponding months of
2008, possibly reﬂecting a decline due to the changed target
age range and recall interval then being implemented in the
screening programme or because women who were due for
screening in this period had already attended for their tests a
few months earlier. These raw monthly data suggest that
about 370,000 extra attendances occurred around the time
that Jade Goody died; and a further 110,000 or so in the
month or two after her diagnosis was made public.
Provisional data from the ﬁrst six months of 2010–11 also
suggest a lesser peak in attendances in March 2010 at
around the ﬁrst anniversary of Jade Goody’s death.
Attendances byage
Annual data for 2008–09 show that increases of 15% or
more were seen for women aged 25–49, but other age
groups showed no or little change (50–54) or even a
decline. The number of attendances in age group 20–24
had been dropping swiftly as the raising of the invitation
age to 25 was taking effect. The rate of fall in the period of
interest was over 15% but a slower decline than had recently
been seen. The Poisson model suggests there were 23,000
extra attendances of women not in the target age range,
almost all of whom were aged under 25. For the 25–29
age group, adding together the model data from autumn
2008 and spring 2009, there were an estimated 31,000
extra call attendances over ﬁve months.
Large decreases in annual screening rates were seen in age
groups 55–59, 60–64 and 65–69 as expected with the
Figure 1 Monthly attendances for cervical screening, England April
2004 to March 2010
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However, Figure 2 shows that the monthly data do indeed
show a spike centred on March 2009 across the age
groups; and groups below age 50 also show the smaller
peak in autumn 2008.
Using the Poisson model to estimate the deviations from
trends for each age group separately suggests that overall
there were about 105,000 extra attendances in autumn
2008 and 396,000 extra attendances in spring 2009. Of the
501,000 extra attendances, 478,000 were for women in
the target age range of 25–64.
Attendances by invitationcategory
Of the 478,000 extra attendances of women in the target age
range 25–64, 332,000 were for routine recall, 42,000 for
ﬁrst call (mostly aged 25–29) and 65,000 were repeats for
surveillance. Repeats following a previous abnormality
accounted for 9000 of the extra attendances and repeats
following an inadequate sample for 13,000.
Attendances by timesincelast test
The Exeter system records, for each attendance, the time
since the woman’s last test and data were extracted in
six-month bands. Distributions by time since last test vary
considerably according to the invitation category, so each is
considered separately.
About 296,000 of the extra attendances were in women
aged 25–49 on routine recall. Of these, 82,000 or 28%
occurred at 60 months or more since the previous test, com-
pared with about 17% normally. Conversely, 8% of the
extra attendances occurred at under 30 months, compared
with about 5% normally. A similar pattern was observed
for women aged 50–64.
Repeat attendances for surveillance post colposcopic treat-
ment usually occur about 12 months after a previous attend-
ance. Of the 66,000 extra attendances for surveillance
30,000 (46%) occurred at 18 months or more after the
index test; this compares with about 26% normally and
suggests that some 18,000 women attended for surveillance
after treatment for Cervical Intraepithelial Neoplasia (CIN)
who might not otherwise have done so.
Of the 9000 extra repeat attendances following an earlier
abnormality, typically required at six months, 2500 (29%)
occurred at 12 or more months after the test with the
abnormality. Typically, only 17% occur after this length of
time, which suggests that some 1200 women were retested
who would not otherwise have been.
Repeats following an inadequate sample usually occur less
than six months after the inadequate sample; only about 2%
take place after 12 months or more. Of the 13,000 extra
attendances for a repeat following an inadequate smear,
7000 (55%) were this late. Also it is noteworthy that from
summer 2009 onwards the proportion of repeats following
an inadequate smear that occurred within six months of
the ﬁrst test was higher than at any time since January 2006.
Figure 2 Monthly attendances for cervical screening by age, England April 2004 to March 2010
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There was an excess of attendances resulting in all test out-
comes. The distribution of outcomes in the extra attendances
was very similar to the usual distribution of outcomes. Of the
results for the 501,000 extra attendances, 6350 were moder-
ate dyskaryosis or worse (1.3%), of which 370 were sus-
pected neoplasia.
Attendances by region
The increase in attendance showed no major variation by
region although there were slight differences in when each
region hit its peak.
Colposcopyappointments
The number of colposcopy appointments rose from 377,000
in 2007–08 to 406,000 in 2008–09 (an 8% increase) and to
454,000 in 2009–10 (a further 12%). There was an increase
from 2008–09 onwards in the proportion of appointments
where the woman attended – 87% compared with 85%
in earlier years (cancelled appointments have been excluded
from this calculation).
DISCUSSION
Previous instances of media cancer stories or celebrity cancer
diagnosis have been seen to affect take up of screening.
1,2
Jade Goody’s cervical cancer diagnosis and the publicity
prior to and after her death can likewise be documented
using screening statistics and conﬁrms the powerful effect
a media story or event can have on the public’s health-
care behaviour.
The extra attendances attributed to the publicity about
Jade Goody did not come at a time when the screening pro-
gramme itself was in a stable state. The changes to the target
age range and to the recall interval had been announced in
October 2003. However, whilst implementation of the
changes had started in spring 2004, a woman’s next due
date was retained until her next attendance; thus this
change to the screening programme had not been fully
implemented even by early 2009. This has complicated the
analysis and necessitated complex modelling.
When allowances are made for these changes in the
structure of the screening programme at around the time of
Jade Goody’s diagnosis and death, the ﬁgures suggest that
the extra attendances were from across the whole range of
ages in the target age group (plus some outside) and across
alltypesofscreeninginvitationcategories.However,themag-
nitude of the effect appeared to decrease with age; this could
bebecausethewomenwhowereclosesttoJadeGoodyinage
or circumstances, that is younger women and women with
young families, were most affected by her experience.
There was concern that the increased attendance might
just have been from the worried well attending for a
repeat screen early. This analysis shows that, if anything,
the opposite is true – a higher proportion of the extra
attendances were among women who were later for their
next test than is usual. This was also reﬂected by the
similar proportion of tests with a high-grade result
(moderate dyskaryosis or worse) among the extra attend-
ances compared with usual.
As with other reported instances of media-activated
increases in screening programme participation, the effect
has been broadly limited in time to the duration of the
media exposure. The spikes in screening attendances in
2008 and 2009 mirrored the publicity covering initial diag-
nosis, announcement of terminal illness and death. A
study of the extent of magazine coverage in 2008 and
2009 showed a ﬁrst peak of interest in August and
September 2008 and then a much more pronounced peak
in March 2009 (26 articles) and April 2009 (19 articles).
6
Just as the number of magazine articles fell back from May
onwards to fewer than 10 per month, so by May (less than
three months after the death) cervical screening attendances
had settled back at about their previous level.
What was not attempted after the 2001 soap opera and
the 2005 Kylie Minogue incidents was a longer term
follow-up which could have revealed any lasting effect of
the publicity. The spike in attendances following Jade
Goody’s death was so pronounced that there should be an
opportunity to examine the screening programme data in
three and ﬁve years’ time to see whether the initial reactive
behaviour translates into a continuing pattern.
Colposcopy information at a national level is too limited to
allow much detailed analysis, but the fall in non-attendances
may also have contributed to cancer prevention and lives
saved. It is not possible to estimate reliably the number of
lives saved by this increased screening. In a subsequent
analysis, it is intended to examine the morbidity and mor-
tality statistics for any evidence of changes that may be
attributed to the increased screening; however, the required
data on incidence in 2009 and on mortality in 2011 and
2012 are not yet available.
CONCLUSION
Jade Goody’s diagnosis and death were highly publicized
and were marked by a substantial increase in attendances
in the cervical screening programme in England. The
pattern of increased attendance mirrored the pattern of
media coverage. Increases were seen in both initial and
follow-up screening attendances and in colposcopy attend-
ances. An increase in screening attendances was observed
at all ages, though the magnitude was greater for women
aged under 50. It is likely that the increased screening
resulted in a number of lives saved but effort should be
made to ensure that the extra women reached return for
regular screening in the future as the effect of celebrity
based publicity appears short lived.
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